Impact of weight change during neoadjuvant chemotherapy on pathologic response in triple-negative breast cancer

Cancer Medicine

Volumn 4, Issue 4, 2015, Pages 500-506

  Bao, Jean ^a   Borja, Nicholas ^a   Rao, Madhu ^a   Huth, James ^a   Leitch, A Marilyn ^a   Rivers, Aeisha ^a   Wooldridge, Rachel ^a   Rao, Roshni ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Ki 67; Neoadjuvant chemotherapy; Triple negative breast cancer; Weight change

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; KI 67 ANTIGEN; PLATINUM COMPLEX; TAXANE DERIVATIVE; TUMOR MARKER;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BODY MASS; CANCER ADJUVANT THERAPY; FISHER EXACT TEST; HUMAN; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL; STUDENT T TEST; TREATMENT RESPONSE; TRIPLE NEGATIVE BREAST CANCER; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION; CARCINOMA, DUCTAL, BREAST; COMPLICATION; CONTROLLED STUDY; FEMALE; KINESIOTHERAPY; METABOLISM; MIDDLE AGED; NEOADJUVANT THERAPY; PHYSIOLOGY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; TRIPLE NEGATIVE BREAST NEOPLASMS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOMARKERS, TUMOR; CARCINOMA, DUCTAL, BREAST; EXERCISE THERAPY; FEMALE; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; NEOADJUVANT THERAPY; OBESITY; PILOT PROJECTS; RETROSPECTIVE STUDIES; TRIPLE NEGATIVE BREAST NEOPLASMS; WEIGHT GAIN; WEIGHT LOSS;

EID: 84984863741     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.388     Document Type: Article

References (40)

1. Carey, L. A., C. M. Perou, C. A. Livasy, L. Dressler, D. Cowan, K. Conway, et al. 2006. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492-2502.
2. Hudis, C. A., and L. Gianni 2011. Triple-negative breast cancer: an unmet medical need. Oncologist 16(Suppl. 1):1-11.
3. Kroenke, C. H., W. Y. Chen, B. Rosner, and M. D. Holmes 2005. Weight, weight gain, and survival after breast cancer diagnosis. J. Clin. Oncol. 23:1370-1378.
4. Loi, S., R. L. Milne, M. L. Friedlander, M. McCredie, G. Giles, J. Hopper, et al. 2005. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol. Biomarkers Prev. 14:1686-1691.
5. Senie, R. T., P. P. Rosen, P. Rhodes, M. L. Lesser, and D. W. Kinne 1992. Obesity at diagnosis of breast carcinoma influences duration of disease-free survival. Ann. Intern. Med. 116:26-32.
6. Camoriano, J. K., C. L. Loprinzi, J. N. Ingle, T. M. Therneau, J. E. Krook, and M. H. Veeder 1990. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J. Clin. Oncol. 8:1327-1334.
7. Chen, S., C. M. Chen, Y. Zhou, R. J. Zhou, K. D. Yu, and Z. M. Shao 2012. Obesity or overweight is associated with worse pathological response to neoadjuvant chemotherapy among Chinese women with breast cancer. PLoS ONE 7:e41380.
8. Litton, J. K., A. M. Gonzalez-Angulo, C. L. Warneke, A. Buzdar, S. Kau, M. Bondy, et al. 2008. Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J. Clin. Oncol. 26:4072-4077.
9. Thivat, E., S. Therondel, O. Lapirot, C. Abrial, P. Gimbergues, E. Gadea, et al. 2010. Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse. BMC Cancer 10:648.
10. Gadea, E., E. Thivat, E. Planchat, B. Morio, and X. Durando 2012. Importance of metabolic changes induced by chemotherapy on prognosis of early-stage breast cancer patients: a review of potential mechanisms. Obes. Rev. 13:368-380.
11. Lorincz, A. M., and S. Sukumar 2006. Molecular links between obesity and breast cancer. Endocr. Relat. Cancer 13:279-292.
12. Yager, J. D., and N. E. Davidson 2006. Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 354:270-282.
13. Guarneri, V., F. Piacentini, G. Ficarra, A. Frassoldati, R. D'Amico, S. Giovannelli, et al. 2009. A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy. Ann. Oncol. 20:1193-1198.
14. Inwald, E. C., M. Klinkhammer-Schalke, F. Hofstadter, F. Zeman, M. Koller, M. Gerstenhauer, et al. 2013. Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res. Treat. 139:539-552.
15. Nishimura, R., T. Osako, Y. Okumura, M. Hayashi, and N. Arima 2010. Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis. Breast Cancer 17:269-275.
16. Billgren, A. M., L. E. Rutqvist, E. Tani, N. Wilking, T. Fornander, and L. Skoog 1999. Proliferating fraction during neoadjuvant chemotherapy of primary breast cancer in relation to objective local response and relapse-free survival. Acta Oncol. 38:597-601.
17. Rao, R., V. Cruz, Y. Peng, A. Harker-Murray, B. Haley, H. Zhao, et al. 2012. Bootcamp during neoadjuvant chemotherapy for breast cancer: a randomized pilot trial. Breast Cancer 6:39-46.
18. Phipps, A. I., D. S. Buist, K. E. Malone, W. Barlow, P. Porter, K. Kerlikowske, et al. 2012. Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann. Epidemiol. 22:340-348.
19. Phipps, A. I., K. E. Malone, P. L. Porter, J. R. Daling, and C. I. Li 2008. Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women. Cancer Epidemiol. Biomarkers Prev. 17:2078-2086.
20. Stead, L. A., T. L. Lash, J. E. Sobieraj, D. Chi, J. Westrup, M. Charlot, et al. 2009. Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res. 11:R18.
21. Gofin, J., and R. Gofin 2011. Essentials of global community health. Jones & Bartlett Learning, Sudbury, MA.
22. Brazda, A., J. Estroff, D. Euhus, A. Leitch, J. Huth, V. Andrews, et al. 2010. Delays in time to treatment and survival impact in breast cancer. Ann. Surg. Oncol. 17(Suppl 3):291-296.
23. Ahn, J., A. Schatzkin, J. V. Jr Lacey, D. Albanes, R. Ballard-Barbash, K. Adams, et al. 2007. Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch. Intern. Med. 167:2091-2102.
24. Suzuki, R., N. Orsini, S. Saji, T. J. Key, and A. Wolk 2009. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status-a meta-analysis. Int. J. Cancer 124:698-712.
25. Suzuki, R., T. Rylander-Rudqvist, W. Ye, S. Saji, and A. Wolk 2006. Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: a prospective cohort study. Int. J. Cancer 119:1683-1689.
26. Goodwin, P. J., M. Ennis, K. I. Pritchard, D. McCready, J. Koo, S. Sidlofsk, et al. 1999. Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J. Clin. Oncol. 17:120-129.
27. Levine, E. G., J. M. Raczynski, and J. T. Carpenter 1991. Weight gain with breast cancer adjuvant treatment. Cancer 67:1954-1959.
28. Nissen, M. J., A. Shapiro, and K. K. Swenson 2011. Changes in weight and body composition in women receiving chemotherapy for breast cancer. Clin. Breast Cancer 11:52-60.
29. Tredan, O., A. Bajard, A. Meunier, P. Roux, I. Fiorletta, T. Gargi, et al. 2010. Body weight change in women receiving adjuvant chemotherapy for breast cancer: a French prospective study. Clin. Nutr. 29:187-191.
30. Caan, B. J., M. L. Kwan, G. Hartzell, A. Castillo, M. Slattery, B. Sternfeld, et al. 2008. Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control 19:1319-1328.
31. Demark-Wahnefried, W., B. K. Rimer, and E. P. Winer 1997. Weight gain in women diagnosed with breast cancer. J. Am. Diet. Assoc. 97:519-526529; quiz 27-28.
32. Demark-Wahnefried, W., E. P. Winer, and B. K. Rimer 1993. Why women gain weight with adjuvant chemotherapy for breast cancer. J. Clin. Oncol. 11:1418-1429.
33. McTiernan, A., K. B. Rajan, S. S. Tworoger, M. Irwin, L. Bernstein, R. Baumgartner, et al. 2003. Adiposity and sex hormones in postmenopausal breast cancer survivors. J. Clin. Oncol. 21:1961-1966.
34. Modugno, F., K. E. Kip, B. Cochrane, L. Kuller, T. Klug, T. Rohan, et al. 2006. Obesity, hormone therapy, estrogen metabolism and risk of postmenopausal breast cancer. Int. J. Cancer 118:1292-1301.
35. McCullough, M. L., H. S. Feigelson, W. R. Diver, A. V. Patel, M. J. Thun, and E. E. Calle 2005. Risk factors for fatal breast cancer in African-American women and White women in a large US prospective cohort. Am. J. Epidemiol. 162:734-742.
36. Lu, Y., H. Ma, K. E. Malone, S. Norman, J. Sullivan-Halley, B. Strom, et al. 2011. Obesity and survival among black women and white women 35 to 64 years of age at diagnosis with invasive breast cancer. J. Clin. Oncol. 29:3358-3365.
37. Kwan, M. L., W. Y. Chen, C. H. Kroenke, E. Weltzien, J. Beasley, S. Nechuta, et al. 2012. Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res. Treat. 132:729-739.
38. Caan, B. J., M. L. Kwan, X. O. Shu, J. Pierce, R. Patterson, S. Nechuta, et al. 2012. Weight change and survival after breast cancer in the after breast cancer pooling project. Cancer Epidemiol. Biomarkers Prev. 21:1260-1271.
39. Chan, D. S., A. R. Vieira, D. Aune, E. Bandera, D. Greenwood, A. McTiernan, et al. 2014. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann. Oncol. 25:1901-1914.
40. Garrow, J. S., and C. D. Summerbell 1995. Meta-analysis: effect of exercise, with or without dieting, on the body composition of overweight subjects. Eur. J. Clin. Nutr. 49:1-10.